A novel Vdelta1 engager targeting CD19 enhances human Vdelta1 gammadelta T cell responses against CLL and CD19+ hematological malignancies. (academic.oup.com)

Authors: Bhumbra SA … Hutton AJ Journal: Journal of Immunology Published: 2026-07-10 DOI: https://doi.org/10.1093/jimmun/vkag167